Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in combination with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer [NA]
This Northwestern University-sponsored trial evaluated Vitamin D supplementation for women at increased risk of ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers [Phase 2]
Phase II trial evaluating debulking surgery with HIPEC followed by intraperitoneal chemotherapy for recurrent ovarian, primary peritoneal, a…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial of vinorelbine plus gemcitabine for platinum-resistant recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer [Phase 2]
Phase 2 trial assessing gemcitabine and docetaxel in relapsed or refractory ovarian epithelial or peritoneal cancer has completed with resul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer [Phase 2]
Phase 2 trial of birinapant in advanced epithelial ovarian, fallopian tube, and peritoneal cancers was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]
Phase 1 trial update evaluating PET/CT imaging with MK-0000-143 in relapsed ovarian cancer, primary peritoneal cancer, and fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib malate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer [Phase 3]
Phase 3 trial assessing nintedanib added to paclitaxel and carboplatin vs placebo in first-line treatment of ovarian cancer; results were po…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 evaluation of cisplatin plus paclitaxel in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Phase 1]
Phase 1 trial investigating carboplatin, paclitaxel, and pegfilgrastim in patients with Stage III/IV ovarian epithelial, fallopian tube, pri…
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 trial of Acetyl-L-Carnitine hydrochloride to prevent chemotherapy-induced peripheral neuropathy in patients with recurrent ovarian…
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating VTX-2337, a TLR8 agonist, in combination with pegylated liposoma…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
Phase 2 trial evaluating sunitinib in recurrent and refractory ovarian, fallopian tube, and peritoneal cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating bevacizumab (Avastin) in epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer;…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating the safety of BIBF 1120 (nintedanib) in combination with Carboplatin and pegylated liposomal doxorubicin in patient…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating imatinib (Gleevec) and gemcitabine (Gemzar) in patients with epithelial ovarian cancer and primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma [Phase 2]
Phase 2 trial of pemetrexed plus bevacizumab for recurrent ovarian cancer and primary peritoneal cancer has completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission [Phase 3]
Phase 3 trial evaluating paclitaxel in patients with advanced ovarian, fallopian tube, or primary peritoneal cancer in remission has complet…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1]
This completed Phase 1 trial evaluated a combination chemotherapy regimen with autologous peripheral stem cell transplant in patients with s…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
The clinical trial evaluated whether serotonin level influences chemotherapy-induced constipation in patients with ovarian, fallopian tube, …
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer [Phase 2]
Phase 2 study of oral ENMD-2076 in ovarian, fallopian tube, and peritoneal cancers has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-18Clinical Trial Update: A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma [Phase 2]
A Phase II study evaluated dasatinib (Sprycel) in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, trabectedin, and G-CSF or pegfilgrastim in patients with recurrent or persistent ovaria…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating topotecan for recurrent ovarian epithelial, fallopian tube, or primary peritoneal cancer, with resu…